Position in BIO
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$2,283,798
-$72,740,160 QoQ
Shares Held
8,193
-96.7% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 99.97558891736848.ToString("F0")%
Shared 0.ToString("F0")%
None 0.02441108263151471.ToString("F0")%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Boston Partners holds $845,303,270 across 12 Medical Devices names. BIO ranks #7 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GEHC |
GE HealthCare Technologies Inc.
|
5,097,700 | $362,854,284 | |
| 2 | STE |
STERIS plc
|
862,253 | $190,670,005 | |
| 3 | MDT |
Medtronic plc
|
2,027,905 | $175,717,968 | |
| 4 | ZBH |
Zimmer Biomet Holdings, Inc.
|
569,009 | $51,449,793 | |
| 5 | HAE |
Haemonetics Corp
|
556,679 | $31,374,427 | |
| 6 | CTKB |
Cytek Biosciences, Inc.
|
5,802,773 | $25,358,118 | |
| 7 | BIO |
Bio-Rad Laboratories, Inc.
This page
|
8,193 | $2,283,798 | |
| 8 | SNN |
Smith & Nephew PLC
|
59,303 | $1,884,649 |
All Filings in BIO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,283,798 | 8,193 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $75,023,958 | 247,612 | Shares | Other | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||